These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29189167)

  • 1. 3D-QSAR and in-silico Studies of Natural Products and Related Derivatives as Monoamine Oxidase Inhibitors.
    Dhiman P; Malik N; Khatkar A
    Curr Neuropharmacol; 2018; 16(6):881-900. PubMed ID: 29189167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docking-Related Survey on Natural-Product-Based New Monoamine Oxidase Inhibitors and Their Therapeutic Potential.
    Dhiman P; Malik N; Khatkar A
    Comb Chem High Throughput Screen; 2017; 20(6):474-491. PubMed ID: 28413973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined 3D-QSAR and docking analysis for the design and synthesis of chalcones as potent and selective monoamine oxidase B inhibitors.
    Mellado M; González C; Mella J; Aguilar LF; Viña D; Uriarte E; Cuellar M; Matos MJ
    Bioorg Chem; 2021 Mar; 108():104689. PubMed ID: 33571810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the Molecular Determinant of Reversible Human Monoamine Oxidase B Inhibitors Containing 2H-Chromen-2-One Core: Structure-Based and Ligand-Based Derived Three-Dimensional Quantitative Structure-Activity Relationships Predictive Models.
    Mladenović M; Patsilinakos A; Pirolli A; Sabatino M; Ragno R
    J Chem Inf Model; 2017 Apr; 57(4):787-814. PubMed ID: 28291352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting monoamine oxidase inhibitory activity through ligand-based models.
    Vilar S; Ferino G; Quezada E; Santana L; Friedman C
    Curr Top Med Chem; 2012; 12(20):2258-74. PubMed ID: 23231398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, Biological Evaluation, and Molecular Simulation of Chalcones and Aurones as Selective MAO-B Inhibitors.
    Morales-Camilo N; Salas CO; Sanhueza C; Espinosa-Bustos C; Sepúlveda-Boza S; Reyes-Parada M; Gonzalez-Nilo F; Caroli-Rezende M; Fierro A
    Chem Biol Drug Des; 2015 Jun; 85(6):685-95. PubMed ID: 25346162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comprehensive Review of Monoamine Oxidase-A Inhibitors in their Syntheses and Potencies.
    Rehuman NA; Mathew B; Jat RK; Nicolotti O; Kim H
    Comb Chem High Throughput Screen; 2020; 23(9):898-914. PubMed ID: 32342809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacophore Modeling, 3D-QSAR and Molecular Docking of Furanochalcones as Inhibitors of Monoamine Oxidase-B.
    Mathew B; Dev S; Suresh J; Mathew GE; Lakshmanan B; Haridas A; Fathima F; Krishnan GK
    Cent Nerv Syst Agents Med Chem; 2016; 16(2):105-11. PubMed ID: 25788143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quercetin and Related Chromenone Derivatives as Monoamine Oxidase Inhibitors: Targeting Neurological and Mental Disorders.
    Dhiman P; Malik N; Sobarzo-Sánchez E; Uriarte E; Khatkar A
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positional scanning of natural product hispidol's ring-B: discovery of highly selective human monoamine oxidase-B inhibitor analogues downregulating neuroinflammation for management of neurodegenerative diseases.
    Hassan AHE; Kim HJ; Gee MS; Park JH; Jeon HR; Lee CJ; Choi Y; Moon S; Lee D; Lee JK; Park KD; Lee YS
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):768-780. PubMed ID: 35196956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico design of novel 2H-chromen-2-one derivatives as potent and selective MAO-B inhibitors.
    Pisani L; Farina R; Nicolotti O; Gadaleta D; Soto-Otero R; Catto M; Di Braccio M; Mendez-Alvarez E; Carotti A
    Eur J Med Chem; 2015 Jan; 89():98-105. PubMed ID: 25462230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent and highly selective dual-targeting monoamine oxidase-B inhibitors: Fluorinated chalcones of morpholine versus imidazole.
    Mathew B; Baek SC; Thomas Parambi DG; Lee JP; Mathew GE; Jayanthi S; Vinod D; Rapheal C; Devikrishna V; Kondarath SS; Uddin MS; Kim H
    Arch Pharm (Weinheim); 2019 Apr; 352(4):e1800309. PubMed ID: 30663112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor.
    Zarmouh NO; Eyunni SK; Soliman KF
    BMC Complement Altern Med; 2017 Jan; 17(1):34. PubMed ID: 28069007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Natural and Synthetic 1,4-naphthoquinones as Inhibitors of Monoamine Oxidase.
    Mostert S; Petzer A; Petzer JP
    Chem Biol Drug Des; 2016 May; 87(5):737-46. PubMed ID: 26684482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective MAO-B inhibitors: a lesson from natural products.
    Carradori S; D'Ascenzio M; Chimenti P; Secci D; Bolasco A
    Mol Divers; 2014 Feb; 18(1):219-43. PubMed ID: 24218136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human monoamine oxidase A and B by flavonoids isolated from two Algerian medicinal plants.
    Larit F; Elokely KM; Chaurasiya ND; Benyahia S; Nael MA; León F; Abu-Darwish MS; Efferth T; Wang YH; Belouahem-Abed D; Benayache S; Tekwani BL; Cutler SJ
    Phytomedicine; 2018 Feb; 40():27-36. PubMed ID: 29496172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.
    Bautista-Aguilera OM; Esteban G; Bolea I; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Samadi A; Soriano E; Unzeta M; Marco-Contelles J
    Eur J Med Chem; 2014 Mar; 75():82-95. PubMed ID: 24530494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: An overview and update.
    Tripathi RKP; Ayyannan SR
    Med Res Rev; 2019 Sep; 39(5):1603-1706. PubMed ID: 30604512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of novel thiazolyl hydrazone derivatives as potent dual monoamine oxidase-aromatase inhibitors.
    Evren AE; Nuha D; Dawbaa S; Sağlık BN; Yurttaş L
    Eur J Med Chem; 2022 Feb; 229():114097. PubMed ID: 34998057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of monoamine oxidase by 8-phenoxymethylcaffeine derivatives.
    Okaecwe T; Swanepoel AJ; Petzer A; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2012 Jul; 20(14):4336-47. PubMed ID: 22705191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.